An incredible amount of work with really brilliant people made #BMTCTN 1703 a success and the new SOC for #GvHD prophylaxis #PTCyRules #BMTCTN CIBMTR Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis | NEJM nejm.org/doi/full/10.10…

Clinical Impact of Cryopreservation of Allogeneic Hematopoietic Cell Grafts During the Onset of the COVID-19 Pandemic ashpublications.org/bloodadvances/… Our CIBMTR analysis of outcomes of cryopreserved grafts during the pandemic. OS same; but risk of relapse and PGF higher with Cryo.

What a great way to celebrate Robin Roberts 10 years since her stem cell transplant Memorial Sloan Kettering Cancer Center by showing her ongoing support for @BeTheMatch efforts to recruit donors for all patients #bmtsm #healthequity

Amazing work by Leslie Kean, MD, PhD and her team, CIBMTR @BeTheMatch and many others for achieving first ever U.S. FDA approval for a drug to prevent acute #GVHD . Historic day for BMT field!

#ASH21 Oral: The 𝐔𝐧𝐬𝐭𝐨𝐩𝐩𝐚𝐛𝐥𝐞 CIBMTR @BTMPublicPolicy @BeTheMatch 👏:Neither COVID19, Nor Cryopreservation, Prevented Allogeneic Product Infusion.
✔️9294 collected, 9085 infused
✔️544 ave infused/mo
✔️Recipients of COVID+ donor did not acquire infection
Steven Devine

Activation alert! #BMTCTN 1903/AMC-109 Auto-RESIST study is open to enrollment:
Administration of HIV-specific T cells to HIV+ Patients Receiving High Dose Chemotherapy Followed by Autologous Stem Cell Rescue
clinicaltrials.gov/ct2/show/NCT04…
Kieron Dunleavy Steven Devine AMC Operations

Although #BMT is the only known cure for MDS, many people aren’t aware of BMT or think that they’re too old to have one because of its side effects. Learn more about this BMT CTN study: cibmtr.org/ReferenceCente…

Great to be back live ASTCT CRTC. Looking forward to working with the wonderful scholars and great faculty. #ClinicalResearch #bmtsm #tcellrx

Big news drop this morning on #CARTcell study @sloan_kettering contributed to: Kite Announces Yescarta® CAR T-cell Therapy Improved EFS by 60% Over Chemo + Stem Cell Transplant in 2nd Line Rel/Ref Large B-cell Lymphoma #lymsm #practicechanging businesswire.com/news/home/2021…

Important City of Hope study with encouraging results in MMUDs using PBSC and PTCy. Further rationale for soon to be activated @BeTheMatch NMDP MMUD study called ACCESS. ashpublications.org/bloodadvances/…

Out in Blood Advances Blueprint for the discovery of biomarkers of toxicity & efficacy for #CARTcells and T-cell engagers. Report from ASH workshop Steven Pavletic M.D., Ph.D. Sophie Paczesny Marcelo Pasquini Leslie Kean Steve Spellman Amit Agarwal Bernatchez Gust Staedtke ashpublications.org/bloodadvances/…

7/ Conclusions: First study of MGTA-145 + plerixafor in multiple myeloma shows promising efficacy for same day mobilization, well tolerated.

Looking forward to completing the study and further development of this agent for improving stem cell mobilization. #ASCO21 #mmsm

The Center for International Blood and Marrow Transplant Research (CIBMTR) Launches Study of #COVID19 Vaccine Immunogenicity in Patients With Hematological Malignancies Who Have Received #CellularTherapy businesswire.com/news/home/2021…

We are elated that the TRANSPLANT Act passed! And, our advocates are too!💚💙👏👏

Join our #BTMAdvocateAllStars and share with us what renewing our federal Program means to you!

Increasing Donor Options in Allogenic Hematopoietic Cell Transplantation ascopubs.org/doi/full/10.12… Very nice Journal of Clinical Oncology editorial about @BeTheMatch study that will 'rejuvenate' interest in mismatched URD Tx. I agree with Mohamad Mohty and Florent Malard

Post-HCT Cyclophosphamide Boosts Transplant Success medpagetoday.com/hematologyonco…. Nice interview with Dr Bronwen Shaw about @BeTheMatch mismatched URD study recently published in Journal of Clinical Oncology It's about creating good options for all patients regardless of #Race

Did you know that not all marrow transplants requires bone marrow? Peripheral blood stem cells (PBSC) are another option that provide life-saving treatments to patients in need. The PBSC donation process is similar to donating plasma. Want to learn more? ms.spr.ly/6014VWWcn

Important CIBMTR study out in Blood Journal Better survival for MUD vs Haplo in RIC Allo. Reminds us Haplo not yet ready to take over from MUD. Gr8 job Rizwan Romee & colleagues #bmtsm ashpublications.org/blood/article/…

Finally an 🍎s to 🍎s comparison of donor sources! MUD clearly > Haplo related = MMUD. Important study that shows matching does matter when controlling for GVHD prophylaxis. 15-MMUD results to be published soon as well.